Bacterial endotoxin testing (BET) is a critical safety checkpoint within the biopharmaceutical industry, in areas from incoming raw materials, in-process testing, and WFI, to final manufactured product release.
However, conventional testing methods have historically caused unnecessary bottlenecks as reliable, objective, and repeatable results could not be quickly and easily obtained.
As these pressures continue to increase, microbiological quality control and production environments are beginning to set the standard for implementing reliable, compliant, and cutting-edge testing methods and technologies through automated bacterial endotoxin testing methods...
Register now to download this exclusive article
